Previous 10 | Next 10 |
home / stock / vvcif / vvcif news
Toronto, Ontario--(Newsfile Corp. - September 19, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company ") has entered into an agreement dated September 15, 2022 with the majority beneficial owner of its outstanding unsecured convertible debentures dated February...
Net revenue for Q2 2022 was $5.2 million Company announced that Canna Farms received a Research Licence from Health Canada in June, 2022 Canadian Launch of Fireside™ Pink Kush and Girl Scout Cookies Full-Spectrum 510 Vapes Australian sales delayed due to new re...
Toronto, Ontario--(Newsfile Corp. - July 22, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company "), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, C...
Toronto, Ontario--(Newsfile Corp. - July 2, 2022) - VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQB: VVCIF ) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders he...
Toronto, Ontario--(Newsfile Corp. - June 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company "), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Ca...
Net revenue for Q1 2022 was $6.9 million VIVO continues to pursue its international expansion strategy which now represents >50% of cannabis revenue Canadian Launch of Canna Farms Single-strain Oils, Infused Pre-rolls, Top Cola Signature Series and Fireside CBD Canna Bliss 510 ...
Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million. In February 2021, closed a $7.2 million equity raise to help fund VIVO's growth In July 2021, the Company elected a new Board of Directors, announced the appointment of Ray Laflamme as CEO and Cha...
Vivo Cannabis (OTCQB:VVCIF) is collaborating with Cicatrix Labs to offer Assuage vaginal and rectal suppositories on VIVO's Canna Farms e-commerce marketplace. The company said the Assuage suppositories for vaginal and rectal use are available in two formulations: 50 mg cannabidiol (CBD), and...
Toronto, Ontario--(Newsfile Corp. - February 11, 2022) - VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiarie...
Toronto, Ontario--(Newsfile Corp. - December 21, 2021) - VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company ") is pleased to announce the appointment of Shai Altman and Glen Huber to the board of directors of the Company (the " Board "), effective immediately. "I a...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio Canada NewsWire BARRIE, ON , April 3, 2023 /CNW/ - MediPharm Labs Corp . (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", or "MediPharm Labs") and VIVO Ca...
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a final court order (the " Final Order ") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced pl...